\begin{table}
    \centering
\begin{tabular}{|p{3cm}|p{9cm}|}
\hline
\textbf{Cell type}     & \textbf{Markers} \\ \hline
Multiple myeloma cells & CD138, CD38 (lower than plasma cells), SLAMF7,  BCMA, KRAS, IGKC, IGCL2. Reduced/ no CD20, CD19, CD45 expression.   \\ \hline
Normal plasma cells    & CD38, CD19, some BCMA \\ \hline
B cells                & CD20, some CD19 \\ \hline
T cells                &  TRAC, CD3D  \\ \hline
Cytotoxic cells        &  GZMH,  GZMB,  GZMA,  PRF1  \\ \hline
CD4+ T cells           & CCR7, SELL, TCF7 and T cell markers  \\ \hline
CD8+ T cells           & CD8A, cytotoxic markers and T cell markers  \\ \hline
NK cells               & KLRB1, KLRC1, KLRF1, CD16 and cytotoxic markers \\ \hline
Dendritic cells        & CD1C, FCER1A  \\ \hline
Monocytes              & CD14/CD16, CD68 \\ \hline
\end{tabular}
\caption[MM annotation gene marker expression]{Manual annotation markers for cell types originating from transcriptomic profiles of bone marrow samples.
SLAMF7, BCMA, KRAS, IGKC and IGCL2 are very highly expressed by MM cells, but are not exclusive to this cluster.
MM patient CD45\textsuperscript{+} immune cells scRNA-seq marker annotation can be found \cite{zavidij2019single}.}
\label{tab:annotation_markers}
\end{table}